TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+20.55%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$899M
AUM Growth
+$899M
(+22%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
3.18%
Top 10 Holdings %
Top 10 Hldgs %
55.22%
Holding
69
New
9
Increased
12
Reduced
10
Closed
6
Top Buys
| 1 |
Amgen
AMGN
|
$23.7M |
| 2 |
iShares Biotechnology ETF
IBB
|
$17.6M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$7.72M |
| 4 |
AGN
ALLERGAN INC
AGN
|
$6.65M |
| 5 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$6.11M |
Top Sells
| 1 |
ONXX
ONYX PHARMACEUTICALS INC
ONXX
|
$16.2M |
| 2 |
Puma Biotechnology
PBYI
|
$13.6M |
| 3 |
MDVN
MEDIVATION, INC.
MDVN
|
$6.85M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$6.53M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$5.96M |
Sector Composition
| 1 | Healthcare | 84.05% |
| 2 | Financials | 1.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$140B
| $94.6M | 10.52% | 1,504,712 | – | – |
|
|
2
Regeneron Pharmaceuticals
REGN
$61.5B
| $81.6M | 9.08% | 260,699 -19,060 | -7% | -$5.96M |
|
|
CELG
3
DELISTED
Celgene Corp
CELG
| $78.5M | 8.74% | 510,046 | – | – |
|
4
Biogen
BIIB
$19.4B
| $46.2M | 5.14% | 191,983 | – | – |
|
|
5
Amgen
AMGN
$155B
| $46.1M | 5.13% | 412,143 +212,000 | +106% | +$23.7M |
|
|
ALXN
6
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $43.1M | 4.8% | 371,329 | – | – |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $37.9M | 4.22% | 499,764 +45,600 | +10% | +$3.46M |
|
8
Perrigo
PRGO
$3.27B
| $25M | 2.78% | 202,607 | – | – |
|
|
9
Puma Biotechnology
PBYI
$254M
| $24.6M | 2.74% | 458,816 -252,984 | -36% | -$13.6M |
|
10
Viatris
VTRS
$12.3B
| $18.6M | 2.07% | 488,209 | – | – |
|
|
SHPG
11
DELISTED
Shire pic
SHPG
| $18.5M | 2.06% | 154,153 | – | – |
|
|
AKRX
12
DELISTED
Akorn, Inc.
AKRX
| $18.4M | 2.05% | 935,758 | – | – |
|
|
13
iShares Biotechnology ETF
IBB
$5.6B
| $17.6M | 1.96% | +83,940 | New | +$17.6M |
|
|
WCRX
14
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
| $16.3M | 1.81% | 713,797 -69,000 | -9% | -$1.58M |
|
15
Incyte
INCY
$16.5B
| $16.1M | 1.79% | 421,300 | – | – |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $15.8M | 1.76% | 246,841 +49,600 | +25% | +$3.18M |
|
|
ONXX
17
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $15.5M | 1.72% | 124,238 -129,618 | -51% | -$16.2M |
|
|
AGN
18
DELISTED
ALLERGAN INC
AGN
| $15.1M | 1.68% | 166,577 +73,500 | +79% | +$6.65M |
|
|
CBST
19
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $14.4M | 1.6% | 226,772 -39,200 | -15% | -$2.49M |
|
20
Merck
MRK
$210B
| $14.1M | 1.57% | 296,620 | – | – |
|
21
Teva Pharmaceuticals
TEVA
$21.1B
| $13.4M | 1.49% | 354,476 +43,000 | +14% | +$1.62M |
|
|
AGN
22
DELISTED
Allergan plc
AGN
| $13.2M | 1.47% | 91,500 | – | – |
|
|
23
BioMarin Pharmaceuticals
BMRN
$11.2B
| $13.1M | 1.46% | 181,870 +106,870 | +142% | +$7.72M |
|
24
Hologic
HOLX
$14.9B
| $12.2M | 1.36% | 592,915 | – | – |
|
|
ALR
25
DELISTED
Alere Inc
ALR
| $11.3M | 1.26% | 369,553 +53,000 | +17% | +$1.62M |
|